Clinical Trial Update: Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

View source ↗

Summary

A completed clinical trial from Switzerland assessed thromboembolic risk and the use of prophylaxis in medical patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: University Hospital, Geneva | Conditions: Venous Thromboembolism | Status: COMPLETED